Veriff vs JADBio

Veriff verifies government IDs, selfies, and business records so companies can onboard users, run KYC and AML checks, and block fraud in about six seconds. Its decision engine analyzes behavioral data across each session and is trusted by more than 3,000 companies worldwide, including Instacart, Western Union, Wise, and Monzo. Automated identity checks report roughly 99.6% accuracy.

Many verification vendors license document forensics, liveness, and face-match models from third parties and rebrand the stack. Veriff builds its decision engine, liveness matching, and document forensics in-house, so one team owns accuracy when a case fails review. AML and database checks use named specialist partners listed in its sub-processor documentation rather than hidden behind the brand.

The platform combines document checks, biometric matching, passive liveness detection, and database cross-referencing into one workflow. It supports more than 12,500 government-issued identity documents across 230+ countries and territories, with end-user flows available in 50 languages. Beyond onboarding, Veriff covers proof of address, age validation, AML screening, business verification across 300+ jurisdictions, and ongoing biometric re-authentication.

Financial services, marketplaces, iGaming, mobility, and HR teams use Veriff for KYC, KYB, age assurance, and account reverification at scale. Fraud tools like CrossLinks, FaceBlock, and session video recording help teams spot synthetic identities and repeat offenders across the shared verification network.

JADBio gives life scientists a no-code AutoML workspace for biomarker discovery on multi-omics datasets. You upload curated CSV or delimited files, pick a predictive outcome like disease status or time to event, and the platform runs feature selection, model training, and interpretation without writing Python or R. It handles genomics, transcriptome, proteome, metabolome, clinical phenotype, and image data in one project.

General-purpose AutoML tools treat biology tables like any other spreadsheet. JADBio is built around survival analysis, biomarker ranking, and multi-omics combinations that pharma and academic teams actually publish on. The trade-off is a narrower domain focus and enterprise pricing once you leave the free Basic tier, but you get interpretable feature reports instead of a black-box score.

Oncology researchers, bioinformaticians, and biotech R&D teams use JADBio for early biomarker discovery, disease subtype classification, drug repurposing signals, and trial monitoring. The GUI runs in the browser, a REST API is available on paid Team plans, and the product is also listed on AWS Marketplace for teams that deploy inside AWS.